Cargando…
NEO adjuvant chemotherapy in breast cancer: What have we learned so far?
Neoadjuvant chemotherapy (NACT) in breast cancer has undergone continuous evolution over the last few decades to establish its role in the combined modality management of these tumors. The process of evolution is still far from over. Many questions are still lurking in the minds of oncologists treat...
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Medknow Publications
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2941606/ https://www.ncbi.nlm.nih.gov/pubmed/20931014 http://dx.doi.org/10.4103/0971-5851.68846 |